Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.
To achieve malarial elimination, we must employ interventions that reduce the exposure of human populations to infectious mosquitoes. To this end, numerous antimalarial drugs are under assessment in a variety of transmission-blocking assays which fail to measure the single crucial criteria of a succ...
Prif Awduron: | Upton, L, Brock, P, Churcher, T, Ghani, A, Gething, P, Delves, M, Sala, K, Leroy, D, Sinden, R, Blagborough, A |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2015
|
Eitemau Tebyg
-
Transmission-blocking interventions eliminate malaria from laboratory populations
gan: Blagborough, A, et al.
Cyhoeddwyd: (2013) -
The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium.
gan: Sinden, R, et al.
Cyhoeddwyd: (2012) -
The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium
gan: Sinden, R, et al.
Cyhoeddwyd: (2012) -
A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines
gan: Delves, M, et al.
Cyhoeddwyd: (2012) -
A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines.
gan: Delves, M, et al.
Cyhoeddwyd: (2012)